跳至主要内容
临床试验/NCT01611181
NCT01611181已完成1 期

Iron Substitution After Total Knee Arthroplasty - a Randomized Study

Northern Orthopaedic Division, Denmark1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2006年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Haemoglobin concentration

研究概览

简要总结

Hemoboost is a registered natural product containing specially processed haemolysed haemoglobin and iron dextran. It is marketed for human use on the basis of many years' use and documented effect in veterinary medicine. Iron dextran was introduced for use in human medicine in 1954.

Krauterblut is a registered natural product made from a number of herbs where the active substance is ferrous gluconate. Both drugs have been available for a number of years and have become increasingly popular among patients and healthcare staff due to a reduction in adverse effects.

The objective of this study is to determine the effect and adverse effects of the natural products Hemoboost and Kräuterblut compared with the usually administered ferrous sulphate in knee arthroplasty.

详细描述

Hip and knee arthroplasties are performed with increasing frequency in the western world, and in Denmark approximately 12,000 operations are performed annually (2/1000/year). The perioperative and postoperative blood loss generally constitutes ½ -1½ litres which is frequently associated with symptom-producing anaemia which obstructs mobilisation and increases the risk of complications.

Postoperative iron supplementation for a period of up to 12 weeks is therefore a frequently adopted practice. However, there is no consensus or evidence that support postoperative iron supplementation and the effects of iron deficiency are unclear. It is well-known that iron supplementation causes gastrointestinal adverse effects in up to 25% of cases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 years
  • ASA group I-II

排除标准

  • malignant disorder
  • chronic renal insufficiency
  • urinary tract infection
  • haemorrhagic diathesis
  • haemoglobin < 7 mmol/l
  • dementia or mental disorder incompatible with survey participation

研究组 & 干预措施

Hemoboost (iron supplementation)

Active Comparator

A registered natural product containing specially haemolysed haemoglobin and iron dextran.

干预措施: Hemoboost (Drug)

Kräuterblut (iron supplementation)

Active Comparator

A registered natural product made from a number of herbs with ferrous gluconate as the active substance.

干预措施: Kräuterblut (Drug)

Ferrofumerat (iron supplementation)

Active Comparator

Ferrous sulphate

干预措施: Ferrofumerat (Drug)

结局指标

主要结局

Haemoglobin concentration

时间窗: 3 months

Determine whether peroral iron substitution of Hemo-Boost or Krauterblut results in the same increase of haemoglobin concentration as the usually administered ferrous sulphate. To study the adverse effects of the natural products Hemo-Boost and Krauterblut compared with ferrous sulphate in knee arthroplasty.

次要结局

  • Basic need for facilities(3 months)
  • Level of activity(3 months)
  • Pain measurement(3 months)
  • Consumption af analgesics(3 months)
  • Healing of ulcer(3 months)

研究者

发起方
Northern Orthopaedic Division, Denmark
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验